Y.D. More Investments’s Takeda Pharmaceutical TAK Stock Holding History

Y.D. More Investments’s Portfolio TAK Stock Details TAK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-30,000	Closed	-$427K	–	477
2024 Q3	$427K	Sell	30,000 -1,000	-3%	-$14.2K	0.04%	151
2024 Q2	$401K	Hold	31,000	–	–	0.04%	146
2024 Q1	$431K	Sell	31,000 -1,223,591	-98%	-$17.8M	0.08%	126
2023 Q4	$17.9M	Sell	1,254,591 -126,959	-9%	-$1.8M	3.44%	7
2023 Q3	$21.4M	Sell	1,381,550 -62,460	-4%	-$967K	4.11%	6
2023 Q2	$22.7M	Sell	1,444,010 -54,801	-4%	-$898K	5.23%	5
2023 Q1	$24.7M	Buy	1,498,811 +443,181	+42%	+$7.06M	5.57%	4
2022 Q4	$16.5M	Buy	+1,055,630	New	+$14.7M	4%	5

Other funds holding TAK

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

BIP

Brandes Investment Partners La Jolla, California $14.1B AUM 25.52% 1-Year Est. Return

VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Y.D. More Investments's TAK Position: Q4 2024 in Review

Y.D. More Investments sold out of Takeda Pharmaceutical (TAK) in Q4 2024, closing a stake of 30,000 shares — an estimated $427K sold.

Y.D. More Investments first reported a position in TAK in Q4 2022 and held it in 8 quarters. The position peaked at $24.7M in Q1 2023. 299 funds tracked by Wall St. Rank hold TAK as of Q4 2024.

Y.D. More Investments reported no remaining Takeda Pharmaceutical position as of Q4 2024 after selling out during the quarter.
Y.D. More Investments sold 30,000 Takeda Pharmaceutical shares in Q4 2024, an estimated $427K.
Y.D. More Investments first reported a position in Takeda Pharmaceutical in Q4 2022 and held it in 8 quarters.
Y.D. More Investments's Takeda Pharmaceutical position peaked at $24.7M in Q1 2023.
299 funds tracked by Wall St. Rank held Takeda Pharmaceutical as of Q4 2024.

Based on Y.D. More Investments's 13F filing for Q4 2024, filed 27 Jan 2025.